What Auspex Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Greer R Scott | Director | May 05 | Tender Offer · U | −7,190 | — | — | 0 |
| Proehl Gerald T | Director | May 05 | Tender Offer · U | −1,466 | — | — | 0 |
| Shah Pratik | President and CEO | May 05 | Tender Offer · U | −903,018 | — | — | 0 |
| Schmid John P. | Chief Financial Officer | May 05 | Tender Offer · U | −144,444 | — | — | 0 |
| Flynn James E | 10% owner | May 05 | Tender Offer · U | −973,379 | — | — | 0 |
| Flynn James E | 10% owner | May 05 | Tender Offer · U | −849,426 | — | — | 0 |
| Flynn James E | 10% owner | May 05 | Tender Offer · U | −1,182,943 | — | — | 0 |
| Flynn James E | 10% owner | May 05 | Tender Offer · U | −953,286 | — | — | 0 |
| Flynn James E | 10% owner | May 05 | Tender Offer · U | −490,069 | — | — | 0 |
| Zisson Alex | Director | May 05 | Tender Offer · U | −4,835,731 | — | — | 0 |
| Stamler David A | Chief Medical Officer | May 05 | Tender Offer · U | −1,627 | — | — | 0 |
| Saks Samuel R | Chief Development Officer | May 05 | Tender Offer · U | −67,338 | — | — | 0 |
| Chowrira Bharat M | Chief Operating Officer | May 05 | Tender Offer · U | −8,297 | — | — | 0 |
| Ferguson Rodney A | Director | May 05 | Tender Offer · U | −2,500,589 | — | — | 0 |
| Sarshar Sepehr | Director | May 05 | Tender Offer · U | −242,574 | — | — | 0 |
| Thomas, McNerney & Partners II, Llc | Director | May 05 | Tender Offer · U | −4,835,731 | — | — | 0 |
| Cmea Ventures Vii Lp | 10% owner | Apr 02 | In/At-money Exercise · X | −7,500 | $29.79 | −$223K | 63,589 |
| Cmea Ventures Vii Lp | 10% owner | Apr 02 | In/At-money Exercise · X | −292,500 | $29.79 | −$8.71M | 2,478,021 |
| Stamler David A | Chief Medical Officer | Mar 16 | Open-market sale · S | −2,600 | $80.08 | −$208K | 983 |
| Stamler David A | Chief Medical Officer | Mar 16 | Open-market sale · S | −400 | $79.55 | −$31.8K | 3,583 |
Loading...
